What IV medication is recommended for a patient with a normal EKG, tachycardia, and BP 115/71 mmHg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IV Adenosine is the First-Line Medication for This Patient

For a hemodynamically stable patient with a heart rate of 170 bpm and normal blood pressure (115/71 mmHg), IV adenosine is the recommended first-line medication, administered as a 6 mg rapid IV bolus followed by immediate saline flush, with a repeat 12 mg dose if needed. 1

Clinical Reasoning

Patient Stability Assessment

  • With a BP of 115/71 mmHg, this patient is hemodynamically stable despite the tachycardia 1
  • Heart rate of 170 bpm with a "normal EKG" (presumably narrow-complex) suggests supraventricular tachycardia (SVT) 1
  • Stable patients do not require immediate cardioversion and should receive pharmacologic therapy first 1

Why Adenosine is First-Line

Adenosine is specifically recommended as first-line treatment for narrow-complex tachycardia in stable patients because it:

  • Terminates almost all episodes of PSVT involving the AV node within 30 seconds 2
  • Has an exceptionally short half-life (<10 seconds), allowing rapid repeat dosing if ineffective 2
  • Serves dual purpose: therapeutic (terminates rhythm) and diagnostic (unmasks underlying rhythm during transient AV block) 1
  • Converts 88-93% of true PSVT cases to sinus rhythm 3

Exact Dosing Protocol

Initial dose: 6 mg rapid IV bolus injected as proximal to the heart as possible, followed immediately by rapid saline flush 1

If no response within 1-2 minutes: 12 mg rapid IV bolus with saline flush 1

If still no response: Repeat 12 mg dose once more (some sources support up to 18 mg total) 1

Alternative Medications if Adenosine Fails

If adenosine is ineffective or contraindicated, the following are second-line options for stable narrow-complex tachycardia:

IV calcium channel blockers:

  • Diltiazem: 0.25 mg/kg IV bolus over 2 minutes 1
  • Verapamil: 5-10 mg (0.075-0.15 mg/kg) IV bolus over 2 minutes 1, 4

IV beta-blockers: 1

  • Metoprolol: 2.5-5 mg IV bolus over 2 minutes, can repeat every 10 minutes up to 3 doses 1
  • Esmolol: 500 mcg/kg IV bolus over 1 minute, followed by infusion 1

Critical Safety Considerations

Adenosine must be given with immediate access to:

  • Defibrillator (adenosine can rarely induce ventricular fibrillation, even without accessory pathways) 5
  • Transcutaneous pacing equipment 5, 2
  • Resuscitation equipment 5

Common transient side effects (<1 minute duration):

  • Flushing, dyspnea, chest pain 1, 2
  • Transient AV block (therapeutic effect) 1
  • Brief asystole or bradycardia 2

Contraindications to adenosine:

  • Known pre-excitation syndromes with atrial fibrillation (can cause ventricular fibrillation) 1, 5
  • Second or third-degree AV block without pacemaker 1
  • Sick sinus syndrome without pacemaker 1
  • Severe bronchospasm 1

What NOT to Give

Avoid verapamil or diltiazem if:

  • Wide-complex tachycardia of uncertain etiology (could be ventricular tachycardia) 1
  • Pre-excitation syndromes with atrial fibrillation 1
  • Decompensated heart failure 1
  • Hypotension 1

Amiodarone is NOT first-line for stable narrow-complex tachycardia—it is reserved for wide-complex tachycardia or refractory cases 1

If Patient Becomes Unstable

Immediate synchronized cardioversion is indicated if the patient develops:

  • Hypotension with signs of shock 1
  • Altered mental status 1
  • Chest pain suggesting ischemia 1
  • Acute heart failure 1

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.